NASDAQ: BEAMBeam Therapeutics Inc Stock Ownership - Who owns Beam Therapeutics?
Insider buying vs selling
Have Beam Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Amy Simon | Chief Medical Officer | 2025-04-02 | 20,997 | $17.73 | $372.30kSell |
| John M. Evans | CEO | 2025-04-01 | 30,663 | $18.35 | $562.70kSell |
| Christine Bellon | Chief Legal Officer | 2025-04-01 | 5,674 | $18.35 | $104.12kSell |
| Bethany J. Cavanagh | SVP Finance and Treasurer | 2025-04-01 | 3,015 | $18.35 | $55.33kSell |
| Amy Simon | Chief Medical Officer | 2025-04-01 | 9,566 | $18.35 | $175.55kSell |
| Giuseppe Ciaramella | President | 2025-04-01 | 7,434 | $18.35 | $136.42kSell |
| Bethany J. Cavanagh | SVP Finance and Treasurer | 2025-02-18 | 6,287 | $35.00 | $220.05kSell |
| Christine Bellon | Chief Legal Officer | 2025-02-14 | 9,492 | $7.22 | $68.53kBuy |
| Christine Bellon | Chief Legal Officer | 2025-02-14 | 10,000 | $34.00 | $340.00kSell |
| Christine Bellon | Chief Legal Officer | 2025-02-14 | 508 | $7.22 | $3.67kBuy |
BEAM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when BEAM insiders and whales buy or sell their stock.
BEAM Shareholders
What type of owners hold Beam Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Farallon Capital Management LLC | 9.85% | 8,239,123 | $162.39M | Institution |
| Blackrock Inc | 9.17% | 7,671,939 | $151.21M | Institution |
| Vanguard Group Inc | 9.11% | 7,621,989 | $150.23M | Institution |
| Ark Investment Management LLC | 8.45% | 7,068,029 | $139.31M | Institution |
| Fmr LLC | 7.21% | 6,033,868 | $118.93M | Insider |
| Arch Venture Management LLC | 5.43% | 4,540,132 | $89.49M | Institution |
| Sumitomo Mitsui Trust Group Inc | 4.73% | 3,957,611 | $78.00M | Institution |
| Nikko Asset Management Americas Inc | 4.73% | 3,957,611 | $78.00M | Institution |
| Robert Nelsen | 4.22% | 3,535,572 | $69.69M | Insider |
| Fmr LLC | 3.96% | 3,317,294 | $65.38M | Institution |
BEAM vs Biotech Stocks
Beam Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.